ResearcherCatholic University of KoreaNo recent work listed

Eun Kyoung Jeon

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8243-3226; OpenAlex author ID A5045506274. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper

Papers 2

Prognostic significance of autophagy-related protein expression in resected pancreatic ductal adenocarcinoma. Co-author DOI 10.1097/mpa.0b013e318279d0dc ↗
Comparison of the efficacy and the toxicity between gemcitabine with capecitabine (GC) and gemcitabine with erlotinib (GE) in unresectable pancreatic cancer. Co-author DOI 10.1007/s00432-012-1234-y ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Myung Ah Lee · 2 shared papers, 2012–2013 · strength 0.07
- Paper Prognostic significance of autophagy-related protein expression in resected pancreatic ductal adenocarcinoma. DOI 10.1097/mpa.0b013e318279d0dc ↗
- Paper Comparison of the efficacy and the toxicity between gemcitabine with capecitabine (GC) and gemcitabine with erlotinib (… DOI 10.1007/s00432-012-1234-y ↗
Yoon Ho Ko · 1 shared paper, 2013 · strength 0.04
- Paper Prognostic significance of autophagy-related protein expression in resected pancreatic ductal adenocarcinoma. DOI 10.1097/mpa.0b013e318279d0dc ↗
In Seok Lee · 1 shared paper, 2012 · strength 0.03
- Paper Comparison of the efficacy and the toxicity between gemcitabine with capecitabine (GC) and gemcitabine with erlotinib (… DOI 10.1007/s00432-012-1234-y ↗
Tae Ho Hong · 1 shared paper, 2012 · strength 0.03
- Paper Comparison of the efficacy and the toxicity between gemcitabine with capecitabine (GC) and gemcitabine with erlotinib (… DOI 10.1007/s00432-012-1234-y ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.